The case against Lilly centered on the rebates that drug companies must pay to state Medicaid programs to subsidize some of the cost.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results